Registry Study of Neoadjuvant Therapy in Conjunction with Liver Transplantation for Cholangiocarcinoma

This study collects information about treatments received on patients with unresectable cholangiocarcinoma, a cancer of the bile duct inside the liver that cannot be removed without a liver transplant. Collecting information on patients about tests or procedures that they have had or will have, may help researchers estimate the rates of response to treatment and withdrawal from treatment.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT00301379.

Trial PhaseNo phase specified

Trial TypeNot provided by clinicaltrials.gov

Lead OrganizationSiteman Cancer Center at Washington University

Principal InvestigatorWilliam C. Chapman

• Primary ID201102096
• Secondary IDsNCI-2020-08517
• ClinicalTrials.gov IDNCT00301379